Eyesight and Testosterone

TheWall

New Member
Just before going on TRT, my eyesight in my right eye was getting weaker. I have a hard time reading the computer screen as well as road signs at distance. My prescription was only for my right eye (dominant eye) which is essentially reading glasses strength and corrects a slight astigmatism in my right eye. Essentially, I can squint it out. :) For the 37 years prior to my diagnosis, I had 20/20 vision.

Since going on TRT, over the last two years, my lenses have been corrected twice to be lesser strength than they were originally. My optometrist is stumped because I could essentially read the lower chart without my glasses. The last few months I have very little need for my glasses.

I run into problems with Zinc and sugar. If I take zinc (50 mg picoliniate) daily, after about a week my right eye is fuzzy but corrected by my lenses. After a few days not taking Zinc I can read the screen without my glasses.

Same thing with sugar. I do not eat a lot of sweets, this week was my birthday, vacation and my son's birthday party. I had cake/ice cream for about 3 to 4 days straight where normally I eat a bland high protein diet. This morning my right eye is noticeably weak and I require my glasses to see the screen.

Any thoughts on what would cause this issue?
 
Last edited:
Krenzer KL, Reza Dana M, Ullman MD, et al. Effect of Androgen Deficiency on the Human Meibomian Gland and Ocular Surface. Journal of Clinical Endocrinology & Metabolism 2000;85(12):4874-82. Effect of Androgen Deficiency on the Human Meibomian Gland and Ocular Surface

The purpose of this study was to determine whether the chronic use of antiandrogen medications leads to meibomian gland dysfunction, altered lipid profiles in meibomian gland secretions, decreased tear film stability, and evaporative dry eye. Subjects taking antiandrogen therapy for prostatic indications, as well as age-related controls, were asked to complete a questionnaire that assessed dry eye symptoms and then were given a complete anterior segment examination. Moreover, meibomian gland secretions were obtained from each eye and analyzed by high-performance liquid chromatography/mass spectrometry for the relative content of cholesterol, cholesterol esters, wax esters, diglycerides, triglycerides, and specific molecular species in the diglyceride fraction. Our results demonstrate that patients taking antiandrogen treatment, compared with age-related controls, had a: 1) significant increase in the frequency of appearance of tear film debris, an abnormal tear film meniscus, irregular posterior lid margins, conjunctival tarsal injection, and orifice metaplasia of the meibomian glands; 2) significant increase in the degree of ocular surface vital dye staining; 3) significant decrease in the tear film breakup time and quality of meibomian gland secretions; and 4) significant increase in the frequency of light sensitivity, painful eyes, and blurred vision. In addition, the use of antiandrogen pharmaceuticals was associated with significant changes in the relative amounts of lipids in meibomian gland secretions. Our findings indicate that chronic androgen deficiency is associated with meibomian gland dysfunction and dry eye.


Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci 2002;966:211-22. Androgen Deficiency, Meibomian Gland Dysfunction, and Evaporative Dry Eye - SULLIVAN - 2006 - Annals of the New York Academy of Sciences - Wiley Online Library

OBJECTIVE: We have recently discovered that women with primary and secondary Sjogren's syndrome are androgen-deficient. We hypothesize that this hormone insufficiency contributes to the meibomian gland dysfunction, tear film instability, and evaporative dry eye that are characteristic of this autoimmune disorder. If our hypothesis is correct, we predict: (1) that androgens regulate meibomian gland function, control the quality and/or quantity of lipids produced by this tissue, and promote the formation of the tear film's lipid layer; and (2) that androgen deficiency, due to an attenuation in androgen synthesis (e.g., during Sjogren's syndrome, menopause, aging, complete androgen-insensitivity syndrome [CAIS] and anti-androgen use), will lead to meibomian gland dysfunction and evaporative dry eye. The following studies were designed to test these predictions.

METHODS: Experimental procedures included clinical studies, animal models, and histological, biochemical, molecular biological, and biomedical engineering techniques.

RESULTS: Our results demonstrate that: (1) androgens regulate the meibomian gland. This tissue contains androgen receptor mRNA, androgen receptor protein within acinar epithelial cell nuclei, and Types 1 and 2 5alpha-reductase mRNAs. Moreover, androgens appear to modulate lipid production and gene expression in mouse and/or rabbit meibomian glands; and (2) androgen deficiency may lead to meibomian gland dysfunction, altered lipid profiles in meibomian gland secretions, tear film instability, and evaporative dry eye. Thus, we have found that anti-androgen therapy in men is associated with meibomian gland disease, a decreased tear film breakup time, and functional dry eye. Furthermore, we have discovered that androgen receptor dysfunction in women with CAIS is associated with meibomian gland changes and a significant increase in the signs and symptoms of dry eye. Of interest, we have also found that androgen deficiency is associated with significant and striking alterations in the neutral and polar lipid patterns of human meibomian gland secretions.

CONCLUSIONS: Our findings show that the meibomian gland is an androgen target organ and that androgen deficiency may promote meibomian gland dysfunction and evaporative dry eye. Overall, these results support our hypothesis that androgen deficiency may be an important etiologic factor in the pathogenesis of evaporative dry eye in women with Sjogren's syndrome.
 
Gokce G, Hurmeric V, Mumcuoglu T, Ozge G, Basaran Y, et al. Effects of androgen replacement therapy on cornea and tear function in men with idiopathic hypogonadotropic hypogonadism. Postgrad Med. 2015;1-5. http://informahealthcare.com/doi/abs/10.1080/00325481.2015.1033376

PURPOSE: Idiopathic hypogonadotropic hypogonadism (IHH) is an endocrine disorder defined with the presence of typical clinical signs and symptoms plus laboratory confirmation of serum testosterone (T) levels lower than 300 ng/dl. Androgen replacement therapy (ART) is the first-step treatment of male IHH.

To date, no clinical trial, which investigates the changes on corneal structure and tear function, of systemic ART in men have been published. The objective of this study was to investigate the effects of ART on cornea and tear function in patients with IHH.

MATERIALS AND METHODS: This prospective, interventional study was conducted at the Gulhane Military Medical Academy, Ankara, Turkey, a tertiary referral military hospital. Thirty-four eyes of 17 men with IHH patients were evaluated with Schirmer I test, ultrasound pachymeter, applanation tonometer and confocal microscopy.

A Testosterone compound (Sustanon(R) 250 mg) was administered by intramuscular injection in the course of a 3-week period to induce puberty, and human chorionic gonadotropin (Pregnyl(R) 5000 IU) was administered twice weekly for 3 months to induce fertility.

The patients were re-evaluated at the third month of the treatment. Main Outcome Measures were Schirmer score, central corneal thickness (CCT), intraocular pressure (IOP), endothelial cell density, coefficient of variation and cell shape.

RESULTS: Schirmer scores showed similar results after the treatment compared to pre-treatment levels (p = 0.14). There was no statistically significant difference in CCT and IOP compared to baseline data (p = 0.96, p = 0.73, respectively), and no significant differences were found in corneal endothelial cell density, percentage of cell size variability or hexagonality (p = 0.83, p = 0.58, p = 0.64, respectively).

CONCLUSIONS: This is the first study that investigates the effects of ART on corneal structure and tear function in men. ART seems to have no short-term effects on corneal structure and tear function. Further publications of larger, long-term and controlled studies are needed.
 
interesting topic

I have thought that my eyes got worse due to hormonal experimentation, in particular I think bouts of too high estrogen over the years (or possibly bouts of extremely low estrogens at times also) may have had an effect, but higher clomid doses for sure did at least in the short term but maybe long term, not sure if it is all coincidental though so I keep an open mind still
 
Back
Top